Idera Pharmaceuticals IDRA
$ 0.43
-23.04%
Quarterly report 2023-Q1
added 06-29-2023
Country |
USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Vincent Milano |
Employees in the company |
36 |
Shares |
3.26 M |
Market Cap[1] |
$ 26.6 M |
EBITDA (LTM) |
$ -39.5 M |
P/E (LTM) |
-0.1 |
P/S (LTM) |
4.91 |
EPS (LTM) |
-4.44 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.